Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT07593924

Not yet recruiting

Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)

Pneumococcal Infectious Diseases
NCT07487077

Recruiting

Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

Cholera Vaccination
NCT07352306

Not yet recruiting

Topical Diacerein in Psoriasis Vulgaris (DIA)

Psoriasis Vulgaris
NCT07298200

Recruiting

Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer

Advanced Gastric Cancer
NCT06961721

Not yet recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older

Prevention of Herpes Zoster
NCT06760208

Recruiting

A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

Safety | Pneumococcal Immunization
NCT06676644

Recruiting

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines (influenza)

Elderly | Influenza Vaccines
NCT06262776

Recruiting

Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients (SIR ZOSTER)

Immunosuppression | Vaccine Response Impaired
NCT05596526

Recruiting

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients (MSHINGVAX)

Zoster | Shingles
NCT05133609

Recruiting

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

SARS-CoV-2 Infection
NCT05043246

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease (SIM-PBD)

Covid19 | Adverse Reaction to Vaccine | Diseases, Chronic
NCT04733807

Recruiting

Antibodies Response to mRNA Vaccine Against Covid-19 (SCAREAID)

Covid-19
NCT06033261

Completed

A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Genital Herpes
NCT06963697

Available

Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Cancer
NCT07172074

Completed

Comparing Relative Strengths of Statistical Associations Between Psychological Traits and Vaccination-Related Outcomes I

Vaccination | Vaccination Hesitancy | Vaccination Promotion | Psychological Aspects
NCT05575830

Active, not recruiting

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls (Shingr'HIV)

RZV Vaccine (Shingrix ®)
NCT06147063

Completed

A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 (ARTEMIS-C)

COVID-19 | SARS-CoV-2 Infection
NCT04741828

Completed

Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

Vaccine
NCT05070546

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention
NCT05373485

Completed

Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

COVID-19
NCT06334861

Completed

Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage (CeVOT-Her-Zo)

Herpes Zoster
NCT06224270

Withdrawn

Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications

Inflammatory Bowel Diseases | IBD
NCT02690181

Completed

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

Streptococcus Agalactiae | Bacterial Infection Due to Streptococcus, Group B
NCT05483725

Active, not recruiting

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

COVID-19 | Kidney Diseases | Vaccine Adverse Reaction | Kidney Transplant; Complications | Rejection Acute Renal | Rejection Chronic Renal
NCT05142332

Terminated

PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED (PROCOVAXED)

Vaccine Hesitancy | Covid-19 Vaccine
NCT00066729

Completed

Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer
NCT05875779

Completed

Peer Education as a Strategy to Promote Vaccine Acceptance

Vaccine Acceptance
NCT04866069

Terminated

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults (COVID-19)

Covid19
NCT00361296

Terminated

Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes
NCT05639998

Completed

BBV152/BBV154 Heterologus Prime-Boost Study (BBV152BBV154)

Corona Virus Infection
NCT05450705

Active, not recruiting

V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)

Papillomavirus Infections
NCT04974164

Completed

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

COVID-19
NCT04868981

Completed

Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets

Hepatitis B
NCT03765437

Completed

Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam (GQM10)

Influenza
NCT05341713

Completed

Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination

Vaccine Adverse Reaction | SARS-CoV-2 Acute Respiratory Disease | Epileptic Seizures Related to Drugs
NCT03673345

Completed

Development of Childhood Anti-Influenza Immunity

Influenza | Influenza Immunisation
NCT00426205

Completed

GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies

Refractory Acute Myeloid Leukemia | Myelodysplastic Syndrome RAEB-I or RAEB-II | Refractory CML Myeloid Blast Crisis
NCT01991067

Completed

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Tick Borne Encephalitis
NCT05113472

Completed

Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

Adverse Drug Event
NCT00459316

Completed

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

HIV Infections | Meningitis
NCT01711736

Completed

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age

Influenza
NCT01549509

Completed

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

HIV Infections
NCT03521973

Completed

Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children

Malaria
NCT05026879

Completed

Adverse Events Report of Inactivated COVID-19 Vaccine

COVID-19 | Vaccine Adverse Reaction
NCT03897946

Completed

Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC

Hepatitis B
NCT00955682

Completed

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

Infections, Meningococcal
NCT00142805

Completed

Tricaprilin in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease
NCT00355550

Completed

Tricaprilin In Age-Associated Memory Impairment

Age-Associated Memory Impairment
NCT03140774

Completed

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines (PRISM)

Ebola Virus Disease
NCT02894840

Completed

Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Influenza

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations